Indegene Limited (INDGN.NS)
Indegene Limited operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Bengaluru, KA, IN. The stock last traded at $555.80, down 2.46% on the session, giving a market capitalisation of $133.92B. Its beta of 0.73 implies it has historically moved less than the broad market.
Operating globally with a strong presence in India, Indegene Limited functions as a specialized commercialization partner for the life sciences industry. It provides comprehensive support to biopharmaceutical, emerging biotech, and medical device companies, assisting them from product development and market access to maximizing their impact throughout the product lifecycle. The company's service offerings include enterprise commercial, medical, and clinical solutions, coupled with omnichannel activation strategies and proprietary NEXT technology platforms. Indegene was established in 1998 and its principal operations are based in Bengaluru, India.
Indegene Limited is most often compared with the following Healthcare names: